Epilepsy is more than having seizures. Behavioral and cognitive comorbidities are very common and sometimes affect everyday life and functioning more than seizures.
The WG aims to improve the assessment of cognitive and behavioural comorbidities at disease onset and along the disease course (e.g., treatment-related changes, the impact of epileptic dysfunction, developmental hindrance, mental decline, etc.). Neuropsychology can also serve as a differential diagnostic indicator of epilepsy subtypes and syndromes when related to imaging, electrophysiology, pathology, and genetics data. It allows monitoring of disease dynamics and can be used for outcome and quality control of treatments.
Composed of both adult and paediatric neuropsychologists, it is structured in 2 core subgroups (Children and Adolescents; Adults)
Special Interest Groups, open to those interested to lead them or contribute focusing, between others, on: Patient-centred outcome measures; uniform reporting and neuropsychological data collection; EEG-logged assessment of cognition; Psychosocial consequences of late-onset epilepsies; Epilepsy with continuous spike-wave during slow-wave sleep; Right cerebral hemisphere and Autism Spectrum Disorders; Cognitive outcome of preschool children after epilepsy surgery; Transition from childhood to adulthood.
We lead regular sessions of case presentations to share knowledge on best practices in neuropsychological evaluation and contribute to surgical and non-surgical case discussions. We closely collaborate with WG 18 on challenges “beyond seizures”.
June 2025. Salzburg (Austria). Christoph Helmstaedter. In an adult patient suffering from a non-surgical epileptic encephalopathy what would you recommend as the most appropriate neuropsychological evaluation? What would be the benefit for the patient from such an evaluation?
June 2025. Salzburg (Austria). Andrea Palacio. On what topics, related to the neuropsychological evaluation of children with epilepsy, is the EpiCARE WG you are leading focuses? Why do you consider them as priorities for the patients?
February 2020. Lyon (France). Christoph Helmstaedter.
If you are interested to voluntarily contribute to this WG activities, please use the contact form to let us know.